Skip to content

Effects of Free Fatty Acids and 3-hydroxybutyrate on Protein, Glucose, Lipid Metabolism and Intracellular Signals.

Effects of Free Fatty Acids and 3-hydroxybutyrate on Protein, Glucose, Lipid Metabolism and Intracellular Signals; a Study on Muscle Wasting and Metabolism During Acute Inflammation and Potential Anabolic Mechanisms.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01752348
Enrollment
10
Registered
2012-12-19
Start date
2013-02-28
Completion date
2014-11-30
Last updated
2014-11-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Systemic Inflammatory Response Syndrome

Keywords

sepsis, cytokine release, fever

Brief summary

The investigators hypothesize that the investigators can detect protein-sparing effects of administration of the ketone 3-hydroxybutyrate and free fatty acids during simulation of an acute inflammatory disease. The investigators use the infusion of endotoxin, US standard reference E.coli in healthy subjects as a model for inflammation / infection and to evaluate the effect on protein metabolism using different tracers and the investigators can measure the various intracellular signaling pathways of selected muscle and adipose tissue.

Interventions

OTHEREndotoxin, US standard reference E.coli

Sponsors

University of Aarhus
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
MALE
Age
20 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* 20 \< body mass index \< 30 kg/m2. * written and orally informed consent before enrollment.

Exclusion criteria

* participation in other studies using radioactive tracers or other exposure to radiation (X-rays, scintigraphy etc). * allergy to soy products or eggs * diabetes, any type * epilepsy * ongoing infection * immune deficiency * cardiovascular disease * dysregulated hypertension * primary muscles disease, congenital or acquired

Design outcomes

Primary

MeasureTime frameDescription
Protein metabolism6 hours intervention periodMeasurements of protein oxidation during intervention using radioactive tracer techniques.

Secondary

MeasureTime frameDescription
Activated intracellular signalling pathwaysstudy dayMeasurements on biopsies from muscle and fatty tissue taken on day of study

Other

MeasureTime frame
Other systemic metabolic effects6 hours of intervention

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 5, 2026